The association of TLR2, TLR4, and TLR9 with response to anti‐TNF therapy in IBD has been established despite the fact that TLRs function as the hub of immune responses to gut microbes, leading to the triggering of IBD [54]. The gene discussed is TLR4; the disease is inflammatory bowel disease.